About the GHIT Fund

Board of Directors

  • Representative Director and Chair Kiyoshi Kurokawa, MD Adjunct Professor, National Graduate Institute for Policy Studies
    Chairman, Health and Global Policy Institute

    A graduate of University of Tokyo Faculty of Medicine, Dr. Kurokawa was a professor of medicine in the School of Medicine at UCLA (1979-84) and at the University of Tokyo (1989-96). He also served as Dean of Tokai University School of Medicine (1996-2002), President of Science Council of Japan (2003-06), Science Advisor to the Prime Minister (2006-08), and WHO Commissioner (2005-09). He is currently an executive member of many national and international professional societies,.
    His website:www.kiyoshikurokawa.com/en
  • Vice Chair Peter Piot, MD, PhD Director and Professor of Global Health,
    London School of Hygiene and Tropical Medicine,

    Peter Piot is Director of the London School of Hygiene & Tropical Medicine, and Professor of Global Health. He was also founding Executive Director of UNAIDS and Under Secretary-General of the United Nations (1995-2008), and has served in numerous other international and academic leadership roles. He sits on numerous boards and has received numerous scientific and civic awards, including the Canada Gairdner Global Health Award, Robert Koch Gold medal, and Prix International INSERM, Paris. He was a 2014 TIME Person of the Year (The Ebola Fighters), and received the Prince Mahidol Award for Public Health. In 2013 he was the laureate of the Hideyo Noguchi Africa Prize for Medical Research. Professor Piot co-discovered the Ebola virus in Zaire in 1976, and led research on AIDS, women's health, and public health in Africa. He was knighted as a baron in his native Belgium, and received an honorary knighthood in the U.K. He has published over 500 scientific articles and 16 books.
  • Executive Director BT Slingsby, MD, PhD, MPH CEO, Global Health Innovative Technology Fund

    Dr. Slingsby is CEO and Executive Director of the Global Health Innovative Technology (GHIT) Fund. Previously, he was the global head for access strategies at Eisai Co., Ltd. where he developed new business models for R&D and overlooked market access in the developing world. Dr. Slingsby has helped launch numerous start-ups in Japan and the U.S., and currently advises at the Graduate School of Medicine at the University of Tokyo and Kyoto University. He sits on the Public-Private Partnership Forum at the Institute of Medicine in the U.S., and has published over 50 peer-reviewed articles on medicine and public health in both Japanese and American literature. Dr. Slingsby graduated with honors from Brown University, earned Master’s and Doctorate degrees from Kyoto University and the University of Tokyo, and received his Medical Doctorate from the George Washington University. He is a former professional triathlete and member of the U.S. World Cup Team.
  • Member Mahima Datla Managing Director, Biological E. Limited

    Ms. Mahima Datla is Managing Director of Biological E. Over the past 13 years at BE, she has been involved in strategy and has also served as Senior Vice President of the company. She is currently responsible for strategic operations and projects. She drives Biological E.’s engagement with Government of India as well as the DCVMN and has been a GAVI board member since 2011. She is a graduate in Business Administration Management from Webster University, London.
  • Member Eiji Hinoshita, MD, PhD Director, Global Health Policy Division, International Cooperation Bureau,
    Ministry of Foreign Affairs

    Prior to his current position, Dr. Hinoshita was Director of the Office of International Cooperation at the Ministry of Health, Labour and Welfare. He has held various leadership positions in international and national governments, including the Permanent Mission of Japan to the United Nations; the Niigata Prefectural Government; and the Japan Defense Agency. Dr. Hinoshita received his medical doctorate from Kyushu University (1994) and master’s degrees from Kyushu University (Biochemistry) and the London School of Hygiene and Tropical Medicine (HPPF).
  • Member Ann M. Veneman, JD Former Executive Director, UNICEF
    Former Secretary, United States Department of Agriculture

    Ann M. Veneman has a distinguished career in public service, including serving as Executive Director of the United Nations Children’s Fund (UNICEF) (2005-2010) and as the United States Secretary of Agriculture (2001-2005). Ms. Veneman graduated from the University of California, Davis, received a master’s degree in public policy from the University of California, Berkeley, and a juris doctor degree from the University of California, Hastings College of the Law. In 2009 she was named to the Forbes 100 Most Powerful Women list.
  • Member Hiroyuki Yamaya Director, Office of International Cooperation
    Ministry of Health, Labour and Welfare

    Hiroyuki Yamaya graduated from Hitotsubashi University in 1994 with a Bachelor’s Degree in Law, and currently serves as Director of the Office of International Cooperation at the Ministry of Health, Labour and Welfare. Prior to his current assignment, he served as Director of the Global Health Policy Division, Ministry of Foreign Affairs (2014) and Political Counselor of the Embassy of Japan in Iran (2011-2014). From 2009 to 2011, Mr. Yamaya handled bilateral issues as well as NATO dossiers at the Embassy of Japan in Belgium. Before 2009, he worked at the Foreign Ministry HQ and in the Prime Minister’s Office, conducting intelligence analysis, defense and crisis management, ensuring the security of Japanese nationals overseas, and managing Francophone Africa relations, to name a few.
  • Supervisory Board Member Hikaru Ishiguro, LLM Board Member, Health and Global Policy Institute

    Hikaru Ishiguro is Board Member of Health and Global Policy Institute. Mr. Ishiguro is a graduate of the University of Tokyo and holds a LLM from Harvard Law School. Starting with Sumitomo Bank, he worked with a variety of global financial institutions. Mr. Ishiguro became Comptroller of the University of Tokyo in 2004 upon its incorporation and served in this role for 8 years. He is a member of the New York Sate Bar Association.
  • Supervisory Board Member Ko-Yung Tung, JD Senior Counselor, Morrison & Foerster LLP
    Former Senior Vice President and General Counsel of the World Bank

    Mr. Ko-Yung Tung is an international lawyer with Morrison & Foerster, with extensive experience in both the public and private sectors. He has served as Senior Vice President and General Counsel of the World Bank, where he was instrumental in establishing the Global Fund for AIDS, Tuberculosis and Malaria. He is a Visiting Lecturer at Law at Yale Law School where he teaches a course on “Globalization, Development, Poverty and the Law”. He received his undergraduate degree in physics from Harvard University and his law degree from Harvard Law School.
  • Ex-Officio Kim C. Bush Director, Life Sciences Partnerships, Bill & Melinda Gates Foundation

    Kim C. Bush is Director of Life Sciences Partnerships for the Bill & Melinda Gates Foundation.
    He joined the foundation in September 2011 after completing a 30-year career at Baxter International that included multiple assignments leading the Vaccine, Bio-Therapeutic, and Medical Device related sector businesses.
  • Ex-Officio Richard Seabrook, PhD, MBA Head, Business Development, Innovations, Wellcome Trust

    Richard leads the Business Development Team, Innovations which undertakes due diligence and project management of translation awards, strategic translation awards and seeding drug discovery funding. The Team has responsibility for intellectual property management and its translation such as through licensing or new company formation. Previously, Richard held project management and business development roles in the biotechnology sector and has extensive experience of early-stage funding of life science technologies, commercial transactions, Board, SAB and government.